BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It has become one of the most-studied research peptides in the last decade due to its breadth of activity in pre-clinical tissue-repair models.
Origin
First isolated from gastric juice in the early 1990s, BPC-157 is a 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that does not occur naturally on its own; it is a fragment of a parent body-protection protein.
Mechanism of interest (in vitro)
Pre-clinical literature explores BPC-157's interaction with the nitric oxide system, growth-hormone receptor expression, and modulation of pro-angiogenic factors (VEGFR-2). These pathways are central to the wound-healing response, which is why BPC-157 is so frequently the subject of musculoskeletal and gastrointestinal injury models.
Common research applications
- Tendon and ligament healing models
- Gastric ulcer protection studies
- Vascular regeneration experiments
- Inflammatory bowel models
Laboratory handling
BPC-157 ships from us as a white lyophilised powder at ≥99% purity. Reconstitute with bacteriostatic water as described in our reconstitution guide. Refrigerated reconstituted solutions remain stable for approximately 28 days; freezer storage at −20 °C extends this further.
A note on legality
BPC-157 is sold for laboratory and in-vitro research purposes only. It is not approved for human use in the UK, EU, or US.
Browse our BPC-157 catalog page for current pricing, including pack-of-10 bulk discounts.